B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
about
Structure and Interactions of the Human Programmed Cell Death 1 ReceptorDown-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathwayCD28, CTLA-4 and their ligands: who does what and to whom?The contributions of T-cell anergy to peripheral T-cell tolerance.Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsivenessMice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivoComparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donorsgammadelta T cells: novel initiators of adaptive immunity.Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens.The antigen-presenting cell function of Reed-Sternberg cells.The role of dendritic cells in T cell activation.Functional expression of B7/BB1 on activated T lymphocytesNovel insights in the regulation of the immune system: a report on the FASEB summer research conference on autoimmunity (June 14-19, 2003, Saxton's River, Vermont, USA).Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail.Expression and co-stimulatory function of B7-2 on murine CD4+ T cells.Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis
P2860
Q27676419-B009D370-FAE1-438F-B5B1-AC056E4D3CA9Q34001670-46F9E529-6E6A-4E91-B33B-0AA95D9A8FE1Q34049974-EBA98EFB-F349-41CC-962D-039F5A43CA50Q34308870-349B9EBC-BD32-4615-9E6E-A93F5FEEB6F6Q35157542-69F29F07-CF22-4F16-90F4-4095E0B2DA64Q36362877-E70A22FF-2BA7-42BE-9731-576A3BD30664Q36363597-F597E434-891F-4069-9212-C252C21DF1CDQ36689807-A6404BB9-16B5-4B29-9015-B68214FDC919Q36732665-8C0BCB38-4FE2-489D-B169-BD5567CCE975Q39023294-01834D5B-B809-4061-871A-0C57DF4D5F75Q40696909-5037FDD3-7C04-4506-8060-C523C075FA9CQ40958145-2A9419B2-7B50-4224-9F7E-22E6DE3F12C0Q41550864-DCA0E0AD-5F8D-499F-9B28-92640C85FB26Q41898118-621E469C-17DE-4161-9971-F638FD6CBB81Q41949996-04AED2B4-2E11-4596-85C5-870C651A3D13Q42676587-7BB025F6-6B6A-490F-BB07-BD8ABCC163E7Q52039725-0F4B851B-1505-43AD-AC99-8862ED079F6AQ52894906-53AD61AF-F5D1-4496-9D22-30E515F11AB8Q56906350-B676B408-8C9C-4CD2-ABC6-6C3F039FE0A2
P2860
B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
@en
type
label
B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
@en
prefLabel
B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
@en
P356
P1476
B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro
@en
P2093
P304
P356
10.1002/EJI.1830230148
P407
P577
1993-01-01T00:00:00Z